ImmunologybioRxiv
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice
V. Dasari, K. Beckett, S. Horsefield…·R. Khanna
This paper develops a bivalent CMV vaccine using gB and polyepitope protein with CpG1018, showing durable humoral and cellular immunity in HLA-expressing mice.
DOI 10.1371/journal.ppat.1010403